DSIP 15mg × 10 vials

A synthetic sleep-related neuropeptide studied for sleep-regulation research, stress-response models, circadian rhythm pathways, neuroendocrine signaling, pain-response mechanisms, recovery-related protocols, and broader nervous-system regulation research.

Product Overview

Compound: DSIP / Delta Sleep-Inducing Peptide
Strength: 15 mg per vial
Injection type: Research protocol dependent
Frequency: Research protocol dependent

Reconstitution

Amount in vial: 15 mg
BAC water: 2 mL
Amount per unit: 75 mcg per unit

Research Dose

Protocol dependent.

Notes

DSIP, or Delta Sleep-Inducing Peptide, is described as a naturally occurring neuropeptide originally studied in relation to sleep regulation and slow-wave sleep pathways. It has been examined for its potential role in neuroendocrine signaling, stress adaptation, circadian rhythm research, and nervous-system regulation.

Research literature has examined DSIP in relation to sleep architecture models, stress-response modulation, opioid and pain-response pathways, hypothalamic-pituitary regulation, recovery-related mechanisms, and autonomic nervous-system activity.

Most available evidence comes from laboratory, animal, and limited clinical-context research. No standard consumer dosing protocol should be assumed.

Use only within appropriate research or professional guidance frameworks.